Showing 1 - 10 of 13,162
Longitudinal, disease-level data are used to analyze the impact of pharmaceutical innovation on longevity (mean age at … pharmaceutical innovation increased mean age at death by 0.87 years (10.4 months) - about 44% of the total increase in longevity … pharmaceutical innovation. The baseline estimate of the cost per life-year gained from pharmaceutical innovation in Greece is $17 …
Persistent link: https://www.econbiz.de/10010473542
Persistent link: https://www.econbiz.de/10010407486
Persistent link: https://www.econbiz.de/10011817398
Persistent link: https://www.econbiz.de/10011708133
Persistent link: https://www.econbiz.de/10009787998
Persistent link: https://www.econbiz.de/10010417576
Persistent link: https://www.econbiz.de/10010415282
Persistent link: https://www.econbiz.de/10011498384
The debate on whether COVID-19 vaccine patents are slowing down the pace of vaccination and the recovery from the crisis has brought the optimal design of pharmaceutical patent policy to the fore. In this paper we evaluate patent policy in the US pharmaceutical industry. We estimate the effect...
Persistent link: https://www.econbiz.de/10012802183
Persistent link: https://www.econbiz.de/10012439514